A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System

Name: A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System
Published: 2012
License: Public Domain

Astellas Pharma Europe Ltd. · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

adult efficacy immunosuppression infections stem-cells transplantation

clostridium difficile, dificid, infections, clostridium, transplantation, efficacy, adult, stem cells, fidaxomicin, difficile, immunosuppression, vancomycin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 829496
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.